PROCEPT BioRobotics Corporation (PRCT) — Insider Activity & Signal

Healthcare · Medical - Devices · Market cap $1.2B · $21.68 · 52-week range $16.66–$42.43

Recent insider buying

Open-market purchases reported to the SEC (last six months). Option grants and tax-withholding sales are excluded.

Date	Insider	Role	Shares	Price	Value	Source
2026-08-07	Wood Larry L	director, officer: President, CEO	23,900	$20.85	$498,315	SEC Form 4
2026-03-09	Desai Antal Rohit	director	1,300	$25.42	$33,042	SEC Form 4
2026-03-09	Desai Antal Rohit	director	53,818	$24.91	$1,340,348	SEC Form 4
2026-03-09	Desai Antal Rohit	director	43,581	$24.08	$1,049,500	SEC Form 4
2026-03-06	Desai Antal Rohit	director	53,763	$24.10	$1,295,790	SEC Form 4
2026-03-06	Desai Antal Rohit	director	106,554	$23.33	$2,485,713	SEC Form 4
2026-03-05	Desai Antal Rohit	director	24,748	$26.41	$653,528	SEC Form 4
2026-03-05	Desai Antal Rohit	director	142,498	$25.44	$3,625,021	SEC Form 4

Financial health

Altman Z-Score 4.14 · Piotroski F-Score 2/9 · Cash $287M · Debt $78M

ClearOcean signal read

ClearOcean's model currently scores PRCT as a watchlist-level signal (6/10), based on the insider, fundamental and risk data above. This is a factual model output, not advice.

Sources & further reading

Primary filings: SEC EDGAR — PRCT Form 4
How ClearOcean reads insider activity

Last updated August 24, 2026.

ClearOcean is a software research tool, not an investment adviser or broker-dealer. This page aggregates public data (incl. SEC filings) for informational purposes only — it is not investment advice, nor a recommendation, offer or solicitation to buy or sell any security. Past activity does not predict future results. You are solely responsible for your decisions; investing can lose value, up to total loss of capital.